Antimicrobial Drugs

The History of Chemotherapy

Chemotherapy in microbiology refers to the use of chemicals to treat infectious diseases. The development of antimicrobial drugs has revolutionized medicine, allowing for the effective treatment of bacterial, fungal, and viral infections.

• Selective toxicity: The ability of a drug to target pathogens without harming the host.

• Chemotherapy: The use of chemicals to treat disease, especially infections.

• Antibiotic: A substance produced by a microbe that, in small amounts, inhibits another microbe.

• Antimicrobial drugs: Synthetic substances that interfere with the growth of microbes.

Historical milestones:

• 1928: Fleming discovered penicillin, produced by Penicillium.

• 1932: Prontosil red dye used for streptococcal infections.

• 1940: First clinical trials of penicillin.

• Today: Growing problem of antibiotic resistance.

Why do microbes produce antibiotics? Microbes produce antibiotics to inhibit the growth of competing microorganisms in their environment.

Spectrum of Antimicrobial Activity

Antimicrobial drugs vary in the range of organisms they affect. Understanding their spectrum is crucial for effective treatment and minimizing side effects.

• Narrow spectrum of microbial activity: Drugs that affect a limited range of microbial types.

• Broad-spectrum antibiotics: Drugs that affect a wide range of gram-positive and/or gram-negative bacteria.

• Superinfection: Overgrowth of normal microbiota that is resistant to antibiotics, often due to broad-spectrum antibiotic use.

Collateral damage: Broad-spectrum antibiotics can disrupt normal microbiota, leading to superinfections and other complications.

Table: Spectrum of Activity of Antibiotics and Other Antimicrobial Drugs

Additional info: Table entries inferred from standard textbook content.

The Action of Antimicrobial Drugs

Antimicrobial drugs act through several mechanisms to inhibit or kill pathogens. These mechanisms are designed to exploit differences between microbial cells and host cells.

• Bactericidal: Drugs that kill microbes directly.

• Bacteriostatic: Drugs that prevent microbes from growing.

Five Major Modes of Action

1. Inhibiting cell wall synthesis: Drugs like penicillins prevent the synthesis of peptidoglycan, weakening bacterial cell walls and causing cell lysis. Most effective against Gram-positive bacteria.

2. Inhibiting protein synthesis: Target bacterial 70S ribosomes, which are different from eukaryotic 80S ribosomes. Examples include chloramphenicol, erythromycin, streptomycin, and tetracyclines.

3. Inhibiting nucleic acid synthesis: Interfere with DNA replication and transcription by blocking enzymes such as topoisomerase or RNA polymerase.

4. Injuring the plasma membrane: Polypeptide antibiotics change membrane permeability; antifungal drugs combine with membrane sterols, disrupting fungal cell membranes.

5. Inhibition of essential metabolite synthesis: Drugs like sulfanilamide compete with para-aminobenzoic acid (PABA), inhibiting folic acid synthesis necessary for bacterial growth.

Equation (Competitive inhibition):

Where E = enzyme, S = substrate, ES = enzyme-substrate complex, P = product. Competitive inhibitors resemble S and block the active site.

Common Antimicrobial Drugs

Most antibiotics are bacteria-specific due to differences in cell wall structure, ribosomes, and metabolic pathways. For each antibiotic, it is important to know its function and spectrum of activity.

• Penicillins: Inhibit cell wall synthesis; mainly affect Gram-positive bacteria.

• Tetracyclines: Inhibit protein synthesis; broad-spectrum, affecting both Gram-positive and Gram-negative bacteria.

• Chloramphenicol: Inhibits protein synthesis; broad-spectrum.

Selective toxicity: Targets unique to bacteria (e.g., peptidoglycan, 70S ribosome) are more likely to be selectively toxic.

Antiviral Drugs

Antiviral drugs are designed to target specific steps in viral replication. Because viruses use host cell machinery, it is challenging to develop drugs that do not harm host cells.

• Attachment

• Penetration

• Uncoating

• Viral replication and assembly

• Viral release

Main classes: nucleoside analogs and enzyme inhibitors. Most effective when viruses are actively replicating. Latent viruses are difficult to treat.

Examples: HIV, herpes viruses, hepatitis viruses, influenza viruses.

Antifungal, Anti-protozoal, and Anti-helminthic Drugs

Drugs targeting eukaryotic pathogens are more challenging to develop due to similarities with host cells and complex life cycles.

• Antifungal drugs: Target fungal cell walls, plasma membranes, or nucleic acid synthesis.

• Anti-protozoal and anti-helminthic drugs: Often target intracellular components; effectiveness may vary depending on the life cycle stage of the parasite.

Challenges: Eukaryotic parasites have complex life cycles and share many cellular features with host cells, making selective toxicity difficult.

Resistance to Antimicrobial Drugs

Microbial resistance to drugs is a major public health concern. Resistance can arise through genetic mutations or acquisition of resistance genes.

• Persister cells: Microbes with genetic characteristics allowing survival when exposed to antibiotics.

• Superbugs: Bacteria resistant to large numbers of antibiotics.

• Horizontal gene transfer: Resistance genes spread among bacteria via plasmids (conjugation or transduction).

Mechanisms of Resistance

1. Prevention of penetration to the target site within the microbe

2. Enzymatic destruction or inactivation of the drug (e.g., β-lactamase production)

3. Alteration of the drug's target site

4. Rapid efflux (ejection) of the antibiotic

Antibiotic Misuse and Safety

Misuse of antibiotics accelerates the development of resistance. Safety considerations are essential in prescribing antimicrobial drugs.

• Using outdated or weakened antibiotics

• Using antibiotics for viral infections (e.g., common cold)

• Using antibiotics in animal feed

• Failing to complete the prescribed regimen

• Using someone else's leftover prescription

Therapeutic index: Ratio of risk to benefit; higher index indicates safer drugs.

Other safety concerns: Drug interactions, organ damage, risk to fetus.

Future of Chemotherapeutic Agents

Research is ongoing to develop new antimicrobial strategies to combat resistance and improve efficacy.

• Targeting virulence factors

• Sequestering iron to starve pathogens

• Antimicrobial peptides: Produced by various organisms, including bacteriocins from bacteria

• Phage therapy: Use of bacteriophages to target bacterial pathogens

Challenges: Specificity, resistance development, and regulatory hurdles.

Summary Table: Major Drug Classes and Their Targets

Additional info: Table entries inferred from standard textbook content.